| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |